KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Return on Sales (2020 - 2025)

Clover Health Investments' Return on Sales history spans 6 years, with the latest figure at 0.0% for Q3 2025.

  • For Q3 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Sep 2025 reached 0.0%, changed 0.0%, while the annual FY2024 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Sales reached 0.0% in Q3 2025 per CLOV's latest filing, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q1 2023 to a low of 0.93% in Q4 2021.
  • Average Return on Sales over 5 years is 0.15%, with a median of 0.01% recorded in 2023.
  • Peak YoY movement for Return on Sales: tumbled -53bps in 2021, then skyrocketed 85bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.93% in 2021, then soared by 91bps to 0.08% in 2022, then surged by 90bps to 0.01% in 2023, then surged by 79bps to 0.0% in 2024, then skyrocketed by 80bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Return on Sales are 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025).